JP2022511497A5 - - Google Patents

Info

Publication number
JP2022511497A5
JP2022511497A5 JP2021531817A JP2021531817A JP2022511497A5 JP 2022511497 A5 JP2022511497 A5 JP 2022511497A5 JP 2021531817 A JP2021531817 A JP 2021531817A JP 2021531817 A JP2021531817 A JP 2021531817A JP 2022511497 A5 JP2022511497 A5 JP 2022511497A5
Authority
JP
Japan
Application number
JP2021531817A
Other languages
Japanese (ja)
Other versions
JP2022511497A (ja
JPWO2020118202A5 (https=
JP7497353B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/064980 external-priority patent/WO2020118202A1/en
Publication of JP2022511497A publication Critical patent/JP2022511497A/ja
Publication of JPWO2020118202A5 publication Critical patent/JPWO2020118202A5/ja
Publication of JP2022511497A5 publication Critical patent/JP2022511497A5/ja
Priority to JP2024086821A priority Critical patent/JP2024101017A/ja
Application granted granted Critical
Publication of JP7497353B2 publication Critical patent/JP7497353B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021531817A 2018-12-06 2019-12-06 Esr1変異を含むモデルにおいて癌を治療するための方法 Active JP7497353B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024086821A JP2024101017A (ja) 2018-12-06 2024-05-29 Esr1変異を含むモデルにおいて癌を治療するための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862776338P 2018-12-06 2018-12-06
US62/776,338 2018-12-06
PCT/US2019/064980 WO2020118202A1 (en) 2018-12-06 2019-12-06 Methods for treating cancer in models harboring esr1 mutations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024086821A Division JP2024101017A (ja) 2018-12-06 2024-05-29 Esr1変異を含むモデルにおいて癌を治療するための方法

Publications (4)

Publication Number Publication Date
JP2022511497A JP2022511497A (ja) 2022-01-31
JPWO2020118202A5 JPWO2020118202A5 (https=) 2022-12-19
JP2022511497A5 true JP2022511497A5 (https=) 2022-12-19
JP7497353B2 JP7497353B2 (ja) 2024-06-10

Family

ID=69158304

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021531817A Active JP7497353B2 (ja) 2018-12-06 2019-12-06 Esr1変異を含むモデルにおいて癌を治療するための方法
JP2024086821A Pending JP2024101017A (ja) 2018-12-06 2024-05-29 Esr1変異を含むモデルにおいて癌を治療するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024086821A Pending JP2024101017A (ja) 2018-12-06 2024-05-29 Esr1変異を含むモデルにおいて癌を治療するための方法

Country Status (17)

Country Link
US (2) US20220016052A1 (https=)
EP (1) EP3890835A1 (https=)
JP (2) JP7497353B2 (https=)
KR (1) KR20210100135A (https=)
AU (1) AU2019392908B2 (https=)
BR (1) BR112021010141A2 (https=)
CA (1) CA3121918A1 (https=)
EA (1) EA202191256A1 (https=)
IL (1) IL283655A (https=)
JO (1) JOP20210138B1 (https=)
MA (1) MA54393A (https=)
MX (1) MX2021006412A (https=)
MY (1) MY208702A (https=)
PH (1) PH12021551327A1 (https=)
SG (1) SG11202105915UA (https=)
UA (1) UA129588C2 (https=)
WO (1) WO2020118202A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI3834824T3 (fi) * 2014-03-28 2025-12-05 Univ Duke Estrogeenireseptoripositiivisen rintasyövän hoito selektiivisellä estrogeenireseptorin modulaattorilla
JP7019422B2 (ja) * 2015-04-29 2022-02-15 ラジウス ファーマシューティカルズ,インコーポレイテッド 癌を治療するための方法

Similar Documents

Publication Publication Date Title
BR112019017762A2 (https=)
BR112021017339A2 (https=)
BR112021017637A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021016996A2 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
BR112021017728A2 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
BR112019016142A2 (https=)
BR112019016138A2 (https=)
BR112021017732A2 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)
BR112021017173A2 (https=)
BR112021017083A2 (https=)